Necroptosis activation is associated with greater methylene blue-photodynamic therapy-induced cytotoxicity in human pancreatic ductal adenocarcinoma cells

Author(s)

de Almeida, Daria R. Q. ; dos Santos, Ancely F. ; Wailemann, Rosangela A. M. ; Terra, Leticia F. ; Gomes, Vinicius M. ; Arini, Gabriel S. ; Bertoldi, Ester R. M. ; Reis, Eduardo M. ; Baptista, Mauricio S. ; Labriola, Leticia

• Document type: Journal article
• Source: PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES; v. N/A, p. 16-pg., 2022-12-10.

Abstract

Pancreatic ductal adenocarcinomas (PDAC) are the fourth leading cause of death due to neoplasms. In view of the urgent need of effective treatments for PDAC, photodynamic therapy (PDT) appears as a promising alternative. However, its efficacy against PDAC and the mechanisms involved in cell death induction remain unclear. In this study, we set out to evaluate PDT's cytotoxicity using methylene blue (MB) as a photosensitizer (PS) (MB-PDT) and to evaluate the contribution of necroptosis in its effect in human PDAC cells. Our results demonstrated that MB-PDT induced significant death of different human PDAC models presenting two different susceptibility profiles. This effect was independent of MB uptake or its subcellular localization. We found that the ability of triggering necroptosis was determinant to increase the treatment efficiency. Analysis of single cell RNA-seq data from normal and neoplastic human pancreatic tissues showed that specific necroptosis proteins RIPK1, RIPK3 and MLKL presented significant higher expression levels in cells displaying a transformed phenotype providing further support to the use of approaches that activate necroptosis, like MB-PDT, as useful adjunct to surgery of PDAC to tackle the problem of microscopic residual disease as well as to minimize the chance of local and metastatic recurrence. (AU)

• FAPESP's process: 17/18922-2 - Development of a computing platform extensible and modular for metabolomics and metagenomics analysis: innovation with the discovery of new enzymatic activities and natural products of pharmaceutical interest derived
• Grantee: Ricardo Roberto da Silva
• Support Opportunities: BIOTA-FAPESP Program - Young Investigators Grants
• FAPESP's process: 17/13804-1 - Mechanisms of detoxification and repair of oxidized biological membranes involving the action of the enzyme peroxiredoxin 6
• Grantee: Alex Inague
• Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
• FAPESP's process: 19/05026-4 - Development of a computational platform extensible and modular for analysis of metabolomics and metagenomics experiments: Innovating with the discovery of new enzymatic activities and derived natural products of interest
• Grantee: Ricardo Roberto da Silva
• Support Opportunities: Scholarships in Brazil - BIOTA - Young Researchers
• FAPESP's process: 15/02654-3 - Multi-User Equipment approved in grant 2014/10492-0 fluorescence microscope
• Grantee: Alexandre Bruni Cardoso
• Support Opportunities: Multi-user Equipment Program
• FAPESP's process: 16/04676-7 - Photodynamic therapy to treat breast cancer: proof of concept pre-clinical studies
• Grantee: Ancély Ferreira dos Santos
• Support Opportunities: Scholarships in Brazil - Post-Doctoral
• FAPESP's process: 17/03618-6 - Unveiling HSPB1's role in prolactin-induced modulation of the unfolded protein response in type 1 Diabetes models
• Grantee: Leticia Labriola
• Support Opportunities: Regular Research Grants
• FAPESP's process: 19/09517-2 - Evaluation of the relationship between energy fluence variation and cell death pathways induced by photodynamic therapy with methylene blue in breast tumors
• Grantee: Gabriel Santos Arini
• Support Opportunities: Scholarships in Brazil - Scientific Initiation
• FAPESP's process: 13/07937-8 - Redoxome - Redox Processes in Biomedicine
• Grantee: Ohara Augusto
• Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC